Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical...
More »SEARCH RESULT
Patent concerns by CP Chandrasekhar
The discussion paper on compulsory licensing of patents will have achieved its purpose if it can lead to a proactive policy in the area of drugs and health. IN a proactive move to ensure a fair balance between protection of intellectual property rights and protection of the public interest, the Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry has chosen to put out a discussion...
More »From approval to appraisal
The government’s subtle, but significant, move to divest the Genetic Engineering Approval Committee (GEAC) of its job of approving the genetically modified (GM) products and convert it into merely a GM appraisal body has taken the biotechnology sector by surprise. The Gazette notification to this effect replaces the word “approval” in the committee’s nomenclature with “appraisal”, thus making it the “Genetic Engineering Appraisal Committee”. One obvious reason for doing so...
More »Will India be the world's fastest growing economy?
The India growth story is enviable. Despite plaguing problems, India has emerged stronger and resilient to the global crisis so far. India is expected to be the world's fastest growing economy by 2018, according to Economist Intelligence Unit (EIU), the research arm of the Economist magazine. India, the second largest growing economy will overtake China as the fastest growing major economy with an average of eight per cent in the...
More »Will India-EU deal make drugs dearer? by Rema Nagarajan
Is the Indian government bargaining away the rights of millions across the world to essential drugs supplied by India, hailed as the pharmacy of the developing world, in the name of free trade with the European Union (EU)? That's a fear being expressed by civil society groups in the developing world. Commerce minister Anand Sharma vehemently denies such a possibility, claiming that the free trade agreement (FTA) under negotiation with...
More »